J&J Revenues Miss Forecasts in Q1 2022, Downgrades FY22 Profit Forecast
(J&J) Johnson & Johnson reported sales of $23.4 billion in the first quarter of 2022, up 5% from the prior year but below the forecast of $23.6 billion. The company…
Johnson & Johnson Q3 Earnings Analysis Preview: What to Expect
Johnson & Johnson stock flat ahead of the Q3 report.Q3 earnings and revenue are expected to top estimates.Focus on medical devices, consumer health, and pharmaceutical businesses. Johnson & Johnson (NYSE:…
J&J Announces $23.31B Q2 Revenue. Forecasts $2.5B from 2021 Vaccine Sales
(Johnson & Johnson) Vaccine maker Johnson & Johnson expects $2.5 billion sales in its Covid-19 vaccine amidst doubts of its effectiveness against the delta variant. The company reported $23.31 billion in…
Supreme Court Decline Appeal by J&J to Compensate Aggrieved Women $2.1B
U.S top court has rejected an appeal by Johnson & Johnson to pay $2.1 billion to women as ordered by a St. Louis jury, according to Bloomberg. The compensatory award…